Migliaccio & Rathod LLP is investigating the Triquetra GLP-Activate supplement. Despite the company’s claim that their product supports healthy appetite control, weight management, and GLP-1 production, there is no reliable scientific evidence demonstrating that these claims are true.
Reported Issues:
Consumers report:
- That this product did not lead to weight loss or appetite suppression as advertised
- That this product was marketed using misleading claims about GLP-1 support
- That they paid for a product that did not provide the promised benefits
- That the supplements were promoted as alternatives to GLP-1 medications, despite not functioning like prescription GLP-1 drugs
- That marketing materials imply that these supplements are scientifically and medically proven and reliable, when evidence may be lacking
- That they would not have purchased the supplements if they had known the claims were not supported by reliable scientific evidence
Why Individuals Should Be Concerned:
Potential claims include:
- Economic loss
- False advertising
- Product defect
- Performance vs. marketing
Signs You May Be Affected:
- You have purchased Triquetra GLP-Activate
- You bought the supplements because they were marketed as supporting GLP-1 production, weight loss, or appetite suppression
- The supplements did not produce the advertised effects
- The supplements produced adverse effects
- You would not have purchased the supplements if you had known the claims were not supported by reliable scientific or medical evidence
If you have encountered these issues, we would like to hear from you. Please complete the contact form on this page, send us an email at [email protected], or give us a call at (202) 470-3520